Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)

Recruiting N/A Interventional Study
Erectile Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Male
Study type
Interventional
Purpose
Treatment
Participants needed
182 (estimated)
Sponsor
Rigicon, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study evaluates the long-term safety and efficacy of the use of the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis in patients with erectile dysfunction. This study follows patients implanted with the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis for up to 3 years after implantation. This study will take approximately 6 months to enroll all subjects. (14 days, 6 week…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male ≥22 years of age. 2. Diagnosed with erectile dysfunction (impotence). 3. Agree to receive Infla10® three-piece IPP as an ED treatment. 4. Willing to complete all protocol required follow-up visits and tests. Exclusion Criteria: 1. Contraindication to general anesthesia…
Contacts

Zeynep Tin Konukcu

888-202-9790

clinical@rigicon.com

CONTACT

Feyzanur CALDIRAN, PhD

888-202-9790

fcaldiran@rigicon.com

CONTACT